These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29520657)

  • 1. SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement.
    Szostakowska M; Szymczyk M; Badowska K; Tudek B; Fabisiewicz A
    Med Oncol; 2018 Mar; 35(4):49. PubMed ID: 29520657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX11 as a minimal residual disease marker for Mantle cell lymphoma.
    Simonsen AT; Sørensen CD; Ebbesen LH; Bødker JS; Bentzen HH; Nyvold CG
    Leuk Res; 2014 Aug; 38(8):918-24. PubMed ID: 24878000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
    Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.
    Sørensen CD; Jørgensen JM; Nederby L; Hokland P; Nyvold CG
    J Immunol Methods; 2014 Apr; 406():131-6. PubMed ID: 24631717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
    Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
    Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of SOX11 in mantle cell lymphoma.
    Lu TX; Li JY; Xu W
    Leuk Res; 2013 Nov; 37(11):1412-9. PubMed ID: 24001358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
    Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
    Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.
    Gimenez E; Chauvet M; Rabin L; Puteaud I; Duley S; Hamaidia S; Bruder J; Rolland-Neyret V; Le Gouill S; Tournilhac O; Voog E; Maisonneuve H; Jacob MC; Leroux D; Béné MC; Formisano-Tréziny C; Gabert J; Gressin R; Callanan MB
    Br J Haematol; 2012 Jul; 158(2):186-197. PubMed ID: 22626453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma.
    Lokvenc M; Kalinova M; Forsterova K; Klener P; Trneny M; Fronkova E; Kodet R
    Ann Hematol; 2018 Mar; 97(3):467-474. PubMed ID: 29273915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
    Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
    Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
    Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?
    Simonsen AT; Schou M; Sørensen CD; Bentzen HH; Nyvold CG
    Leuk Lymphoma; 2015; 56(9):2724-7. PubMed ID: 25629991
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].
    Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
    Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
    Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
    Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
    Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma.
    He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms.
    Chen YH; Gao J; Fan G; Peterson LC
    Mod Pathol; 2010 Jan; 23(1):105-12. PubMed ID: 19801969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.
    Dalland JC; Smadbeck JB; Sharma N; Meyer RG; Pearce KE; Greipp PT; Peterson JF; Kumar S; Ketterling RP; King RL; Baughn LB
    Genes Chromosomes Cancer; 2021 Oct; 60(10):678-686. PubMed ID: 34124820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.